In cancer cells, NBP-generated ROS directly inhibits PI3K/AKT signaling or concurrently activates phosphatase and tensin homolog (PTEN) [92], which negatively regulates the activation of AKT, via oxidizing cysteine residues within the thiol group [93]. The gene discussed is AKT1; the disease is cancer.